These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 37186895)
1. Juniper Berries Regulate Diabetes and Obesity Markers Through Modulating PPAR Chae HS; Dale O; Mir TM; Ashfaq MK; Avula B; Walker LA; Khan IA; Khan SI J Med Food; 2023 May; 26(5):307-318. PubMed ID: 37186895 [TBL] [Abstract][Full Text] [Related]
2. LT175 is a novel PPARα/γ ligand with potent insulin-sensitizing effects and reduced adipogenic properties. Gilardi F; Giudici M; Mitro N; Maschi O; Guerrini U; Rando G; Maggi A; Cermenati G; Laghezza A; Loiodice F; Pochetti G; Lavecchia A; Caruso D; De Fabiani E; Bamberg K; Crestani M J Biol Chem; 2014 Mar; 289(10):6908-6920. PubMed ID: 24451380 [TBL] [Abstract][Full Text] [Related]
3. A Multitarget Approach to Evaluate the Efficacy of Chae HS; Dale O; Mir TM; Avula B; Zhao J; Khan IA; Khan SI Molecules; 2022 Jan; 27(3):. PubMed ID: 35163893 [No Abstract] [Full Text] [Related]
4. PPARα-LXR as a novel metabolostatic signalling axis in skeletal muscle that acts to optimize substrate selection in response to nutrient status. Caton PW; Holness MJ; Bishop-Bailey D; Sugden MC Biochem J; 2011 Aug; 437(3):521-30. PubMed ID: 21609322 [TBL] [Abstract][Full Text] [Related]
5. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia. Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517 [TBL] [Abstract][Full Text] [Related]
6. Oleanolic acid induces a dual agonist action on PPARγ/α and GLUT4 translocation: A pentacyclic triterpene for dyslipidemia and type 2 diabetes. Loza-Rodríguez H; Estrada-Soto S; Alarcón-Aguilar FJ; Huang F; Aquino-Jarquín G; Fortis-Barrera Á; Giacoman-Martínez A; Almanza-Pérez JC Eur J Pharmacol; 2020 Sep; 883():173252. PubMed ID: 32534078 [TBL] [Abstract][Full Text] [Related]
7. Screening of medicinal plants for PPARα and PPARγ activation and evaluation of their effects on glucose uptake and 3T3-L1 adipogenesis. Yang MH; Avula B; Smillie T; Khan IA; Khan SI Planta Med; 2013 Aug; 79(12):1084-95. PubMed ID: 23877921 [TBL] [Abstract][Full Text] [Related]
8. PPARγ and PPARα synergize to induce robust browning of white fat in vivo. Kroon T; Harms M; Maurer S; Bonnet L; Alexandersson I; Lindblom A; Ahnmark A; Nilsson D; Gennemark P; O'Mahony G; Osinski V; McNamara C; Boucher J Mol Metab; 2020 Jun; 36():100964. PubMed ID: 32248079 [TBL] [Abstract][Full Text] [Related]
9. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo. Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927 [TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptors-alpha and gamma are targets to treat offspring from maternal diet-induced obesity in mice. Magliano DC; Bargut TC; de Carvalho SN; Aguila MB; Mandarim-de-Lacerda CA; Souza-Mello V PLoS One; 2013; 8(5):e64258. PubMed ID: 23700465 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression. Patsouris D; Reddy JK; Müller M; Kersten S Endocrinology; 2006 Mar; 147(3):1508-16. PubMed ID: 16357043 [TBL] [Abstract][Full Text] [Related]
12. Cystathionine γ lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes. Cai J; Shi X; Wang H; Fan J; Feng Y; Lin X; Yang J; Cui Q; Tang C; Xu G; Geng B Biochim Biophys Acta; 2016 May; 1861(5):419-29. PubMed ID: 26946260 [TBL] [Abstract][Full Text] [Related]
13. A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice. Shiomi Y; Yamauchi T; Iwabu M; Okada-Iwabu M; Nakayama R; Orikawa Y; Yoshioka Y; Tanaka K; Ueki K; Kadowaki T J Biol Chem; 2015 Jun; 290(23):14567-81. PubMed ID: 25907553 [TBL] [Abstract][Full Text] [Related]
14. A newly identified CG301269 improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferator-activated receptor alpha and gamma. Jeong HW; Lee JW; Kim WS; Choe SS; Kim KH; Park HS; Shin HJ; Lee GY; Shin D; Lee H; Lee JH; Choi EB; Lee HK; Chung H; Park SB; Park KS; Kim HS; Ro S; Kim JB Diabetes; 2011 Feb; 60(2):496-506. PubMed ID: 21270261 [TBL] [Abstract][Full Text] [Related]
15. Lycopene Prevents DEHP-Induced Liver Lipid Metabolism Disorder by Inhibiting the HIF-1α-Induced PPARα/PPARγ/FXR/LXR System. Zhao Y; Ma DX; Wang HG; Li MZ; Talukder M; Wang HR; Li JL J Agric Food Chem; 2020 Oct; 68(41):11468-11479. PubMed ID: 32962341 [TBL] [Abstract][Full Text] [Related]
16. Antidiabetic effect of a flavonoid-rich extract from Sophora alopecuroides L. in HFD- and STZ- induced diabetic mice through PKC/GLUT4 pathway and regulating PPARα and PPARγ expression. Lv Y; Zhao P; Pang K; Ma Y; Huang H; Zhou T; Yang X J Ethnopharmacol; 2021 Mar; 268():113654. PubMed ID: 33271248 [TBL] [Abstract][Full Text] [Related]
17. Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR-γ-knockout (CM-PGKO) mice. Barbieri M; Di Filippo C; Esposito A; Marfella R; Rizzo MR; D'Amico M; Ferraraccio F; Di Ronza C; Duan SZ; Mortensen RM; Rossi F; Paolisso G PLoS One; 2012; 7(4):e35999. PubMed ID: 22563432 [TBL] [Abstract][Full Text] [Related]
18. Fasting promotes the expression of SIRT1, an NAD+ -dependent protein deacetylase, via activation of PPARalpha in mice. Hayashida S; Arimoto A; Kuramoto Y; Kozako T; Honda S; Shimeno H; Soeda S Mol Cell Biochem; 2010 Jun; 339(1-2):285-92. PubMed ID: 20148352 [TBL] [Abstract][Full Text] [Related]
20. P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice. Chen W; Zhou XB; Liu HY; Xu C; Wang LL; Li S Br J Pharmacol; 2009 Jul; 157(5):724-35. PubMed ID: 19422369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]